
Why the US Is Rethinking Newborn Hepatitis B Vaccines – And What It Means for Global Public Health
A powerful US advisory panel has just voted to roll back a 30-year policy that all newborns should receive a hepatitis B vaccine at birth. The move is already rippling through public-health circles worldwide – and could reshape the global vaccine debate in ways that go far beyond one infection.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.